United Therapeutics Corp
NASDAQ:UTHR

Watchlist Manager
United Therapeutics Corp Logo
United Therapeutics Corp
NASDAQ:UTHR
Watchlist
Price: 373.785 USD 3.43% Market Closed
Market Cap: 16.6B USD
Have any thoughts about
United Therapeutics Corp?
Write Note

United Therapeutics Corp
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

United Therapeutics Corp
Total Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
United Therapeutics Corp
NASDAQ:UTHR
Total Equity
$5.7B
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
17%
Abbvie Inc
NYSE:ABBV
Total Equity
$6.8B
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Total Equity
$18.3B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
1%
Amgen Inc
NASDAQ:AMGN
Total Equity
$5.9B
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
-13%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Equity
$14.8B
CAGR 3-Years
17%
CAGR 5-Years
24%
CAGR 10-Years
29%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Equity
$28.2B
CAGR 3-Years
23%
CAGR 5-Years
24%
CAGR 10-Years
28%

See Also

What is United Therapeutics Corp's Total Equity?
Total Equity
5.7B USD

Based on the financial report for Jun 30, 2024, United Therapeutics Corp's Total Equity amounts to 5.7B USD.

What is United Therapeutics Corp's Total Equity growth rate?
Total Equity CAGR 10Y
17%

Over the last year, the Total Equity growth was 5%. The average annual Total Equity growth rates for United Therapeutics Corp have been 16% over the past three years , 17% over the past five years , and 17% over the past ten years .

Back to Top